[CLSTR]
< Back to situations

[PERSON]

Upadacitinib

Featured in 3 tracked stories · first seen

Situations

[QUIET] [HEALTH] [CN] [EU] [IT]

Upadacitinib expanded approval for skin and arthritis

4 clusters · 22 sources · last updated

Latest: European Commission approves upadacitinib for three immune-mediated diseases

Clinical trials for the Janus kinase (JAK) inhibitor upadacitinib have demonstrated success in treating severe alopecia areata by blocking inflammatory signals via the JAK/STAT pathway. Research indicates that up to 23 p

Also covered in